logo
Gene editing: Is humanity ready to rewrite the book of life?

Gene editing: Is humanity ready to rewrite the book of life?

Mint08-05-2025
When Watson and Crick discovered DNA's double helix in 1953, humanity stumbled upon something miraculous and menacing: the ability to edit genes. Not read them, not mildly tweak them, but rewrite them with a divinity complex. Think of it as opening Microsoft Word and creating your fantasy appearance. Rainbow-coloured eyes? Sure. Sounds amazing? It is. Terrifying? Definitely.
Gene editing is like Prometheus handing humanity the genetic matchstick—except this time, instead of fire, we're toying with the instruction manual of life. It all started innocently enough, back in the 1970s, when
scientists
like Herbert Boyer and Stanley Cohen created recombinant DNA, enabling direct gene manipulation across species barriers. The 1980s saw the first genetically modified organisms and transgenic animals, while the 1990s brought the ambitious Human Genome Project.
Also Read:
Genetically engineered animals are here: Regulation mustn't get left behind
By 2003, scientists had mapped 92% of humanity's complete genetic blueprint. The pace quickened with the 2012 invention of Crispr-Cas9, the tool that democratized precise genetic modification through its relative simplicity and affordability. In one bold move, we accelerated both progress and ethical concerns.
Crispr tech is precise, cheap and fast. It is already being used to cure genetic diseases. Between 2023-25, the UK and US approved therapies that cured—and not just treated— sickle cell anaemia. Patients who lived their lives with chronic pain and blood transfusions are now
free of the illness
.
Crispr tech do-it-yourself kits can be bought online. It sounds like a great Diwali gift, until someone starts editing mosquitoes to spread designer viruses or resurrects smallpox as a prank. Amazing and terrifying.
Scientists, meanwhile, are re-programming immune cells to target tumours with high precision. Plant engineering is equally promising. We could soon have drought-resistant rice and bananas that resist going brown. More nutritious and resilient crops that can withstand climate change could revolutionize food security worldwide.
Also Read:
Colossal Biosciences' dire wolf pups aren't proof of gene-tech defeating extinction
As for genetic re-engineering being a bugbear, the Lulu and Nana controversy is a prime example. It involved twin girls born in November 2018 who were the world's first known genetically modified humans, edited as embryos by scientist He Jiankui. He introduced a mutation to make the gene HIV resistant (the girls' father was HIV-positive while their mother wasn't). His secret research was exposed when documents appeared in China's clinical trials registry and other international publications.
The case highlighted the reality of designer babies and underscored the urgent need for an international oversight and governance framework. Genetic inequality has moved beyond science fiction. Today, gene enhancement is available, even if only at a prohibitive cost.
Cloning is another contentious issue that hit the news in 1996, with Dolly being the first cloned mammal. While animal cloning is practised in agriculture and conservation, human cloning remains ethically questionable and mainly in the realm of science fiction.
Also Read:
Genetic studies: Let's cast a wider DNA net
The question of whether human genes should be patented is a hotly contested one. While patents incentivize research and drive innovation, critics argue that naturally occurring genes belong to the entire human race. A 2013 US Supreme Court ruling against Myriad Genetics that invalidated patents on naturally occurring genes like BRCA1 and BRCA2 (linked to breast cancer) set a legal precedent. Yet, synthetic or significantly altered genetic sequences remain patentable.
Now let's then address the 'mammoth' in the room. Are we headed for a real-life
Jurassic Park? The short answer is 'no.' We can't recreate dinosaurs. DNA degrades too fast, with a half-life of about 521 years. The longer answer is 'kind of.'
Colossal Biosciences, a US startup, is working on bringing back woolly mammoths by modifying Asian-elephant DNA. It has tried to resurrect the dodo and dire wolf. This is called 'de-extinction,' but critics call it 'bio-dramatics with unpredictable ecological consequences." Let's not sugar-coat it. Gene modification could widen an already yawning gap between the haves and have-nots. Imagine rich engineered babies growing taller, smarter and resistant to everything except bad wi-fi, while the poor are stuck in queues for basic vaccines. Left unchecked, this could usher in genetic caste systems.
Humanity, never one to resist temptation, has already produced some genetic oddities. Nasa has gene-edited mice to grow larger muscles in space. Scientists are now editing weed to remove the high THC and preserve its medicinal value. And there are also glow-in-the-dark pets: fluorescent cats, pigs and even bunnies.
Also Read:
What does a woolly mammoth have in common with Mars? Nothing, except neither will solve Earth's problems
Gene-editing is a tool like fire or nuclear energy. Used wisely, it can rid us of suffering, feed billions and save species. Used recklessly, it can usher in a genetic dystopia.
The current thinking in science and bioethics is cautiously optimistic. Therapeutic editing is okay, enhancement for aesthetics, intellect or athleticism is hotly debated and editing embryos for heritable traits is mostly banned or heavily restricted, while reviving dinosaurs is not on. As Dr Ian Malcolm grumbled in
Jurassic Park
: 'Your scientists were so preoccupied with whether or not they could, they didn't stop to think if they should." It's finally time to confront that dilemma.
The author is a technology advisor and podcast host.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Scientist and poet embed poem in DNA of near-immortal bacteria, creating a living artwork that could last billions of years
Scientist and poet embed poem in DNA of near-immortal bacteria, creating a living artwork that could last billions of years

Economic Times

time2 days ago

  • Economic Times

Scientist and poet embed poem in DNA of near-immortal bacteria, creating a living artwork that could last billions of years

TIL Creatives Immortal poetry: Scientists encode verse into DNA of 'Conan the Bacteria' to outlast humanity and even the sun. (Representative Image of a encoded bacteria DNA) Canadian poet Christian Bök and University of Texas chemical engineer Lydia Contreras have embedded a poem into the DNA of one of Earth's toughest organisms. This microbe could preserve art for billions of years. In a project that fuses biotechnology with literature, the duo used Deinococcus radiodurans, nicknamed 'Conan the Bacteria', to record verses inside its genetic code. This microbe can survive extreme radiation, freezing, dehydration, and even the vacuum of space, making it virtually immortal by our standards. Under ideal conditions, it could persist for geological timescales, safeguarding human culture far beyond our civilization's research is part of Bök's decades-long literary-scientific experiment, The Xenotext, to turn poetry into a living, self-replicating artifact. Deinococcus radiodurans is considered one of the most resilient lifeforms known to science. Its DNA repair mechanisms allow it to survive doses of radiation thousands of times higher than lethal levels for humans. Scientists believe it could remain intact for billions of years, making it an ideal 'time capsule' for human knowledge and art. The encoded poem, 'Orpheus,' begins with the line 'Any lifestyle is primitive.' When the bacterium 'reads' this genetic sequence, it produces a protein chain that translates into a second, complementary poem, 'Eurydice,' beginning with 'The fairy is pink with shine.' The protein also glows red, creating a visual embodiment of the poem's transformation is possible thanks to a mutually bijective cipher developed by Bök, where each letter of one poem corresponds to a fixed letter in the other. According to a CPG article, the system, which took four years to complete, ensures that both works are perfectly interlinked.Bök first attempted the idea 2015 with a more fragile bacterium, publishing the results in The Xenotext: Book 1. But his ultimate goal was to work with D. radiodurans, whose near-indestructibility would ensure the poem's survival even in catastrophic latest book, The Xenotext: Book 2, represents the result of 25 years of research, trials, and errors.'I wanted to create something that could survive the Sun,' said Bök as quoted by CPG. 'It's a gesture towards preserving human culture across planetary timescales.'Contreras, whose laboratory specializes in the genetic manipulation of D. radiodurans, partnered with Bök to make the project feasible. She called the work 'philosophically exciting,' as it bridges the gap between DNA's genetic language and humans' written language. Beyond its artistic dimension, the project showcases DNA's potential as a long-term data storage medium. Unlike digital files that decay over decades or centuries, biological archives could last indefinitely, perhaps even serving as a message to extraterrestrial civilizations. The project's name and structure are inspired by the ancient Greek myth of Orpheus and Eurydice, a story of love, loss, and the attempt to bring something back from the underworld. In this case, the 'resurrection' is a set of immortal verses engraved in the very code of Bök, it's both a scientific milestone and a poetic statement: 'In the end, it's about how we store information that will survive forever.'

Scientist and poet embed poem in DNA of near-immortal bacteria, creating a living artwork that could last billions of years
Scientist and poet embed poem in DNA of near-immortal bacteria, creating a living artwork that could last billions of years

Time of India

time2 days ago

  • Time of India

Scientist and poet embed poem in DNA of near-immortal bacteria, creating a living artwork that could last billions of years

Canadian poet Christian Bök and University of Texas chemical engineer Lydia Contreras have embedded a poem into the DNA of one of Earth's toughest organisms. This microbe could preserve art for billions of years. In a project that fuses biotechnology with literature, the duo used Deinococcus radiodurans , nicknamed 'Conan the Bacteria', to record verses inside its genetic code. This microbe can survive extreme radiation, freezing, dehydration, and even the vacuum of space, making it virtually immortal by our standards. Under ideal conditions, it could persist for geological timescales, safeguarding human culture far beyond our civilization's lifespan. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Switch to UnionBank Rewards Card UnionBank Credit Card Apply Now The research is part of Bök's decades-long literary-scientific experiment, The Xenotext, to turn poetry into a living, self-replicating artifact. The Bacteria That Could Outlast Humanity Live Events Deinococcus radiodurans is considered one of the most resilient lifeforms known to science. Its DNA repair mechanisms allow it to survive doses of radiation thousands of times higher than lethal levels for humans. Scientists believe it could remain intact for billions of years, making it an ideal 'time capsule' for human knowledge and art. A Poem That Writes Back The encoded poem, 'Orpheus,' begins with the line 'Any lifestyle is primitive.' When the bacterium 'reads' this genetic sequence, it produces a protein chain that translates into a second, complementary poem, 'Eurydice,' beginning with 'The fairy is pink with shine.' The protein also glows red, creating a visual embodiment of the poem's imagery. This transformation is possible thanks to a mutually bijective cipher developed by Bök, where each letter of one poem corresponds to a fixed letter in the other. According to a CPG article, the system, which took four years to complete, ensures that both works are perfectly interlinked. A 25-Year Journey to Fuse Biology and Literature Bök first attempted the idea 2015 with a more fragile bacterium, publishing the results in The Xenotext: Book 1. But his ultimate goal was to work with D. radiodurans, whose near-indestructibility would ensure the poem's survival even in catastrophic scenarios. His latest book, The Xenotext: Book 2, represents the result of 25 years of research, trials, and errors. 'I wanted to create something that could survive the Sun,' said Bök as quoted by CPG. 'It's a gesture towards preserving human culture across planetary timescales.' The Science Behind the Art Contreras, whose laboratory specializes in the genetic manipulation of D. radiodurans, partnered with Bök to make the project feasible. She called the work 'philosophically exciting,' as it bridges the gap between DNA's genetic language and humans' written language. Beyond its artistic dimension, the project showcases DNA's potential as a long-term data storage medium. Unlike digital files that decay over decades or centuries, biological archives could last indefinitely, perhaps even serving as a message to extraterrestrial civilizations. Between Myth and Immortality The project's name and structure are inspired by the ancient Greek myth of Orpheus and Eurydice , a story of love, loss, and the attempt to bring something back from the underworld. In this case, the 'resurrection' is a set of immortal verses engraved in the very code of life. For Bök, it's both a scientific milestone and a poetic statement: 'In the end, it's about how we store information that will survive forever.'

From Independence to Innovation: How India and Genomics Grew Together
From Independence to Innovation: How India and Genomics Grew Together

Time of India

time2 days ago

  • Time of India

From Independence to Innovation: How India and Genomics Grew Together

The 1940s saw the beginning of two remarkable stories. First is India's independence in 1947, and second, the pioneering science of genomics in 1944. Over the past eight decades, India's development and the evolution of genomics have reflected each other's spirit, deeply rooted in developing indigenous capabilities, driven by innovation, and inspired by the vision of a better India. Although DNA was discovered in the latter half of the 19th century, when Friedrich Miescher isolated the hereditary material that was later understood to be DNA, the attempt to decode it was made only in 1944 – when Oswald Avery, Colin MacLeod, and Maclyn McCarty demonstrated its role as carrier of genetic information, laying the foundation for the genomic era. The 1950s & 60s witnessed India's investment in building expertise, with the establishment of CSIR, ICMR, and the IITs. Similarly, on the other side, expertise in genomics was evolving, with Rosalind Franklin's X-ray images showing the DNA structure, Watson and Crick deciphering this structure, and early tools for reading it beginning to emerge. During the 1960s and 70s as India launched its space program, expanded higher education, and began investing in biotechnology, on the genomics front, Frederick Sanger, Allan Maxam, and Walter Gilbert developed methods to sequence DNA and genomics witnessed the birth of recombinant DNA technology giving way to the development of the first drug, human insulin, in 1982. The 1990s brought global integration for India. India's market was unlocked because of Economic liberalisation, unleashing new opportunities in IT, healthcare, and biotechnology. It was also a turning point in the genomics revolution with the launch of the Human Genome Project , aided by automated DNA sequencing and the mapping of disease-related genes. The project was aimed at identifying all the genes in human DNA and determining the sequences of the 3 billion base pairs that make up that DNA. The project took 13 years to complete. Its results opened doors to a new era of precision medicine and targeted disease management. In parallel, the dawn of the millennium also ushered in India as a global services hub. For Indian healthcare, this was also the era of several breakthroughs in clinical research and generics. The last couple of decades have been defined by leadership and innovation. India's digital revolution and the start-up boom showed the world its ability to lead in both scale and speed. In genomics, new technologies such as CRISPR genome editing and next-generation sequencing (NGS) have brought rapid improvements in throughput and cost, making NGS mainstream for research and clinical applications. Global quality genetic diagnostic tests, which can identify the root cause of complex diseases, are now available in India at affordable costs. High-end genetic tests developed in India and validated and backed by credible research stand testimony to India's scientific excellence, innovation, and talent, while also reiterating the country's commitment to its Make in India initiative. Population-scale projects like the Genome India Project aimed at sequencing one million genomes, a national effort by the Department of Biotechnology (DBT) to build a comprehensive reference genome for India, reflect India's contribution to advancing genomics, strengthening precision medicine and ensuring that genomics led early intervention and disease management are accessible to India's diverse and dynamic landscape. As we celebrate the 79th year of independent India, this reflection on India's remarkable journey in parallel with the journey of the source code of our life, our DNA, highlights not just the freedom of governance, but the freedom to have healthier, longer, and better lives. The article is written by Dr Venkataswamy Eswarachari, Senior Director, Lab Operations, MedGenome (DISCLAIMER: The views expressed are solely of the author and does not necessarily subscribe to it. shall not be responsible for any damage caused to any person/organisation directly or indirectly)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store